This report describes a retrospective cohort study evaluating the potential of blood urea nitrogen-to-albumin ratio (BAR) as a prognostic biomarker for patients with acute graft-versus-host disease. Researchers measured BAR within 48 hours of diagnosis. They aimed to investigate its association with mortality, seeking to improve clinical risk stratification.
Read more on Frontiers.
